Max Hallin

发表论文 33 篇 · 总被引 906 次 · h-index 9

代表论文

Targeting the CXCR4 pathway using a novel anti-CXCR4 IgG1 antibody (PF-06747143) in chronic lymphocytic leukemia (2017 · Journal of Hematology & Oncology · 被引 63)
A novel CXCR4 antagonist IgG1 antibody (PF-06747143) for the treatment of hematologic malignancies (2017 · Blood Advances · 被引 51)
Phase II trial of neoadjuvant sitravatinib plus nivolumab in patients undergoing nephrectomy for locally advanced clear cell renal cell carcinoma (2023 · Nature Communications · 被引 49)
Sitravatinib in combination with nivolumab plus ipilimumab in patients with advanced clear cell renal cell carcinoma: a phase 1 trial (2025 · Nature Communications · 被引 12)
A phase II study of sitravatinib (Sitra) in combination with nivolumab (Nivo) in patients (Pts) undergoing nephrectomy for locally-advanced clear cell renal cell carcinoma (accRCC). (2021 · Journal of Clinical Oncology · 被引 11)
Preclinical and clinical studies of a class I/IV HDAC inhibitor, mocetinostat, in melanoma. (2020 · Journal of Clinical Oncology · 被引 9)